Can you explain how CMS is addressing reimbursement for high-cost diagnostic radiopharmaceuticals used in nuclear cardiology?
CMS is updating its reimbursement policies to separately reimburse high-cost diagnostic radiopharmaceuticals, particularly those with a per-day cost exceeding $630. This adjustment ensures accurate payments for nuclear medicine services, which are essential for advanced cardiology imaging. These changes will help support the accuracy of heart disease diagnostics, particularly as technologies like nuclear imaging continue to play a crucial role in assessing cardiac health.
This question was answered in our annual Cardiology Reimbursement & Compliance Update webcast. For more hot topics relating to cardiology services, please visit our store or call us at 1.800.252.1578, ext. 2.
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Copyright © 2025 ICD10monitor. Powered by MedLearn Media.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24